Armata Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.913; its P/E ratio is -1.44; Armata Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.23M	-	-	$ 1.11M	$ 0.00
Gross Profit	$ 1.23M	-	-	-	-
EBIT	$ -14.15M	$ -3.55M	$ -14.49M	$ -10.27M	$ -8.61M
EBITDA	$ -13.97M	$ -3.25M	$ -14.29M	$ -9.97M	$ -8.39M
Net Income Common Stockholders	$ -31.16M	$ -3.55M	$ -14.49M	$ -10.26M	$ -8.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 24.00M	$ 12.50M	$ 25.10M	$ 14.85M	$ 25.38M
Total Assets	$ 112.76M	$ 101.26M	$ 108.78M	$ 95.83M	$ 92.88M
Total Debt	$ 113.63M	$ 68.31M	$ 77.33M	$ 48.81M	$ 39.45M
Net Debt	$ 89.63M	$ 55.81M	$ 52.23M	$ 33.96M	$ 14.06M
Total Liabilities	$ 125.15M	$ 82.07M	$ 86.33M	$ 59.75M	$ 47.30M
Stockholders Equity	$ -12.39M	$ 19.14M	$ 22.45M	$ 36.08M	$ 45.58M
Cash Flow	-
Free Cash Flow	$ -13.24M	$ -12.21M	$ -19.61M	$ -10.03M	$ -11.63M
Operating Cash Flow	$ -9.73M	$ -11.99M	$ -17.60M	$ -10.48M	$ -10.33M
Investing Cash Flow	$ -3.51M	$ -222.00K	$ -2.01M	$ 455.00K	$ -1.29M
Financing Cash Flow	$ 24.80M	$ -368.00K	$ 29.59M	$ -500.00K	$ 31.00K

Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

Income Statement >

Armata Pharmaceuticals Debt to Assets

Balance Sheet >

Armata Pharmaceuticals Cash Flow

Cash Flow >

Armata Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing